The implications of e-commerce for community pharmacy
The Pharmaceutical Journal Vol 265 No 7118 p580
October 14, 2000 The Conference
The implications of e-commerce for community pharmacy
The implications of e-commerce for pharmacy were discussed at a plenary session held on September 10, before Lord Hunt (Parliamentary Under-Secretary of State for Health) revealed the Governments support for electronic prescription transfer and e-pharmacy. Mr Peter Curphey (member of the Royal Pharmaceutical Societys Council) was in the chair
|Will e-commerce replace face-to-face sales in pharmacies?|
The United Kingdom represented a large potential market for online pharmacy services, Mr ANDREW TUCKER (business development manager, Pharmacy2u) told the Conference. The level of use of the internet among the UK population was of a similar proportion to that in the United States, he said, but British consumers had shown a greater inclination to buy online.
So, who was buying pharmaceutical products through the Pharmacy2u website (www.pharmacy2u.com)? The four main groups that the company had identified so far were busy executives, mothers at home, the elderly or disabled and those making embarrassing purchases. The common theme was that they either did not have the time to visit a conventional high street pharmacy or they wanted home delivery for reasons of convenience or privacy.
Pharmacy2u worked on a wholesale model, with central dispatch of products. Speed was of the essence and the company aimed to dispatch orders within six hours of receipt. At present, delivery was made using couriers but Mr Tucker said that he believed that in future the Royal Mail could be used for making deliveries.
A number of future models for e-commerce involving pharmaceuticals were emerging, he said. At present there were four steps in the supply chain: manufacturers delivered to wholesalers which delivered to pharmacies which supplied patients. However, e-commerce and the internet offered the possibility of removing either or both of the intermediate steps between manufacturers and the consumers of their products the patients.
Europe and e-commerce
The European Commission had decided that e-commerce sales of pharmaceutical products were possible within the European Union and that current regulations covering such sales applied to the internet, Mr MARK CLOUGH (partner, Ashurst Morris Crisp) said.
A report for the commission, prepared by Ashurst Morris Crisp, had been presented to a round table meeting chaired by former EU Commissioner Martin Bangemann in December, 1998. Among the obstacles to expanding e-commerce identified in the report were the need to gain marketing authorisation in each member state, while the internet allowed global sales from a single base. There were also strict rules covering the advertising of medicinal products and bans on distance sales or teleshopping. The commission had subsequently tried to interpret its rules on advertising medicinal products to allow key information, such as that contained in the summaries of product characteristics, to be included on websites.
In addition, there were moral and ethical considerations. These were the other side of the story and needed to be given due consideration. Pharmaceuticals were different from other items of commerce, particularly in that they should only be used as and when they were required.
The UK was at the forefront of internet pharmacy within Europe, Mr Clough said. As well as companies such as Pharmacy2u, there was the online version of NHS Direct, which the Government had said it wanted to see available through kiosks in pharmacies.
E-pharmacy or mail order
Going behind the whizzy front-end of online pharmacies, there was still the problem of getting products to patients, Mr JOHN DARCY (director, National Pharmaceutical Association) said. In this respect, e-pharmacy was no different to mail order, something the profession had resisted for over 150 years.
Since the backbone of a typical community pharmacy was its dispensing business, with a standard fee of less than one pound, the only viable e-commerce model was a warehouse one, handling large numbers of prescriptions from a central site. Such a model would seriously undermine the pharmacy network. A more preferable solution was the so called clicks-and-mortar solution, linking online sales to existing pharmacies. This was the only model which had so far proved successful in the US.
There was also the problem of whether patients actually wanted to use online pharmacy systems. This did not seem to be the case in general at present, although use would grow as the population became more used to using the internet. There would always be a need for immediate-use sales too, for which the internet was not ideally suited. Face-to-face sales were preferred for this.
The introduction of electronic prescriptions would bring benefits to all those involved, Mr DArcy said, particularly as information would not have to be rekeyed into different systems.
General medical practitioners would benefit from a decreased administrative workload as the responsibility for managing repeat prescriptions was transferred to community pharmacy. They would also receive better information on prescribing and compliance.
For the National Health Service, there would be the opportunity to develop a consolidated electronic health record. A more transparent and controlled system would give greater opportunity to control fraud.
Direct links between the PPA and pharmacies would lead to a huge improvement on the current system of reimbursement. The paper-based system was state of the Ark and viewed with incredulity by European pharmacists, who saw pharmacists dispatching 4,000 or more invoices per month to the PPA in brown paper bags without any records being kept in the pharmacy.
Citation: The Pharmaceutical Journal URI: 20003296
Recommended from Pharmaceutical Press
This new edition of Dale and Appelbe's Pharmacy and Medicines Law is the definitive guide to law and ethics for pharmacy practice in the UK. It covers law and professional regulation and is firmly established as the definitive student textbook and reference work on this subject in the UK. Fully updated to include changes to pharmacy laws and regulation.£57.00Buy now